Herborium Group Launches Aggressive Social Media Marketing Strategy for AcnEase® Product Line

Nov 10, 2011, 14:07 ET from AcnEase

SADDLE BROOK, N.J., Nov. 10, 2011 /PRNewswire/ -- Herborium Group, Inc., (PK: HBRM) www.herborium.com, a Botanical Therapeutics™ company, announced today that it has retained the services of Extreme Media, a public relations firm specializing in Social Media, to launch the Company's social media marketing campaign for its proprietary acne treatment AcnEase®. This will be one of many steps the Company is taking to make a strong push in the $50 billion global market for acne treatment.

In light of the withdrawal by Hoffmann-La Roche Inc. from further manufacturing and distribution of Accutane® (isotretinoin), the leading treatment for severe acne that is presently a subject of a class action suit, Herborium's AcnEase is perfectly positioned for an exponential growth as it is the all-botanical ingredients based, safe and effective alternative for addressing the acne problems that affect close to 60 million individuals in the US.

Dr. Agnes P. Olszewski, Chairmen and CEO of Herborium noted, "A social media strategy is a very cost effective marketing tool and will allow Herborium to take advantage of the strong consumer trends to pursue natural health alternatives and self medication decisions. The use of social media to educate consumers and healthcare providers about the benefits of AcnEase is an important step in the Company's growth strategy. This key marketing strategy for brand building will be applied to other Herborium products; including our unique all herbal ingredients based Women and Men Sexual Therapeutics."

"Since acne is both a disease and a social affliction, AcnEase bridges the healthcare and personal care (beauty) market making it an ideal candidate for a strategy using a social media platform and will serve as an effective tool to increase both our sales and market share," concluded Dr. Olszewski.

About AcnEase (www.acnease.com)  

AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic® targeting the symptoms of acne in both females and males of all ages. Unlike many herbal products, AcnEase has been validated through clinical testing. The results demonstrated that approximately 95% of the patients with adolescent acne responded positively to AcnEase. In adults with hormonal or chronic acne the level of effectiveness was 85%.  The overall positive response rate to AcnEase was 91%. To date, after 5 plus years on the market, Herborium has registered a 95.5% consumer satisfaction rate for the AcnEase product.

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. The company secured a pipeline of botanical ingredients based products in the areas of Dermatology, Prostate Health (BPH), Liver Diseases and Women's and Men's Health and selected sexual disorders. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission

For more information please inquire: DrAgnes@Herborium.com

SOURCE Herborium Group, Inc.